Medimaps Group raises CHF 18.55 m in Series C financing round

Swiss imaging software developer Medimaps Group has raised CHF 18.55 million in its Series C financing. The round was led by Swisscanto Invest by Zürcher Kantonalbank.  Swisscanto Invest invests on behalf of its clients in Swiss growth companies in the expansion phase.

Medimaps Group is dedicated to the conception, development, manufacture and marketing of software in the healthcare sector, in particular in the field of texture bone analysis. Medimaps Group will use the funds to support the commercialization of deep tech software powered by artificial intelligence (AI) for bone health and expand their product offerings.

Walder Wyss has advised Swisscanto Invest by Zürcher Kantonalbank in connection with medimaps group’s financing round. The Walder Wyss team was led by Alexandre Both (partner, corporate/m&a, pictured) and included Alex Nikitine (partner, corporate/m&a), Grégoire Henriod (senior associate, corporate/m&a), Aurélien Bill (senior associate, corporate/employment) and Riccardo Brazerol (associate, corporate/m&a).